Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
1.205
-0.015 (-1.23%)
Sep 3, 2025, 11:32 AM - Market open

Lineage Cell Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts that cover Lineage Cell Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $4.25, which forecasts a 252.70% increase in the stock price over the next year. The lowest target is $2.00 and the highest is $9.00.

Price Target: $4.25 (+252.70%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$2.00$4.25$3.00$9.00
Change+65.98%+252.70%+148.96%+646.89%

Analyst Ratings

The average analyst rating for Lineage Cell Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy555554
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total555554

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$2
Strong BuyMaintains$2+65.98%Aug 27, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$2
Strong BuyMaintains$2+65.98%Aug 14, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$2
Strong BuyMaintains$2+65.98%Aug 5, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$2
Strong BuyMaintains$2+65.98%Jun 23, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$9
Strong BuyReiterates$9+646.89%Jun 23, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
8.70M
from 9.50M
Decreased by -8.42%
Revenue Next Year
24.25M
from 8.70M
Increased by 178.80%
EPS This Year
-0.15
from -0.09
EPS Next Year
-0.07
from -0.15
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.83M4.34M14.70M8.95M9.50M8.70M24.25M
Revenue Growth
-48.05%137.73%238.70%-39.16%6.19%-8.42%178.80%
EPS
-0.14-0.26-0.15-0.12-0.09-0.15-0.07
EPS Growth
-------
Forward PE
-------
No. Analysts
-----99
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High11.3M44.7M
Avg8.7M24.3M
Low6.1Mn/a

Revenue Growth

Revenue Growth20252026202720282029
High
19.4%
413.7%
Avg
-8.4%
178.8%
Low
-36.0%
-

EPS Forecast

EPS20252026202720282029
High-0.07-
Avg-0.15-0.07
Low-0.21-0.12

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.